Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2025-12-25 @ 10:14 PM
Study NCT ID:
NCT05679258
Status:
COMPLETED
Last Update Posted:
2024-06-28
First Post:
2022-12-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Compare the PK , Safety, Tolerability, and Immunogenicity of HLX15 With Daratumumab in Male Subjects
Sponsor:
Shanghai Henlius Biotech
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-31
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-28
Completion Date Type:
ACTUAL
First Submit Date:
2022-12-21
First Submit QC Date:
None
Study First Post Date:
2023-01-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-27
Last Update Post Date:
2024-06-28
Last Update Post Date Type:
ACTUAL